Loading…

Nitric oxide‐mediated hyporeactivity to noradrenaline precedes the induction of nitric oxide synthase in endotoxin shock

1 The role of an enhanced formation of nitric oxide (NO) and the relative importance of the constitutive and inducible NO synthase (NOS) for the development of immediate (within 60 min) and delayed (at 180 min) vascular hyporeactivity to noradrenaline was investigated in a model of circulatory shock...

Full description

Saved in:
Bibliographic Details
Published in:British journal of pharmacology 1993-03, Vol.108 (3), p.786-792
Main Authors: Szabó, Csaba, Mitchell, Jane A., Thiemermann, Christoph, Vane, John R.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c5739-f81f288a710c650dd3a252a14e2899159ad7be8055ac67a54165b86931da9a563
cites cdi_FETCH-LOGICAL-c5739-f81f288a710c650dd3a252a14e2899159ad7be8055ac67a54165b86931da9a563
container_end_page 792
container_issue 3
container_start_page 786
container_title British journal of pharmacology
container_volume 108
creator Szabó, Csaba
Mitchell, Jane A.
Thiemermann, Christoph
Vane, John R.
description 1 The role of an enhanced formation of nitric oxide (NO) and the relative importance of the constitutive and inducible NO synthase (NOS) for the development of immediate (within 60 min) and delayed (at 180 min) vascular hyporeactivity to noradrenaline was investigated in a model of circulatory shock induced by endotoxin (lipopolysaccharide; LPS) in the rat. 2 Male Wistar rats were anaesthetized and instrumented for the measurement of mean arterial blood pressure (MAP) and heart rate. In addition, the calcium‐dependent and calcium‐independent NOS activity was measured ex vivo by the conversion of [3H]‐arginine to [3H]‐citrulline in homogenates from several organs obtained from vehicle‐ and LPS‐treated rats. 3 E. coli LPS (10 mg kg−1, i.v. bolus) caused a rapid (within 5 min) and sustained fall in MAP. At 30 and 60 min after LPS, pressor responses to noradrenaline (0.3, 1 or 3 μg kg−1, i.v.) were significantly reduced. The pressor responses were restored by NG‐nitro‐l‐arginine methyl ester (l‐NAME, 1 mg kg−1, i.v. at 60 min), a potent inhibitor of NO synthesis. In contrast, l‐NAME did not potentiate the noradrenaline‐induced pressor responses in control animals. 4 Dexamethasone (3 mg kg−1, i.v., 60 min prior to LPS), a potent inhibitor of the induction of NOS, did not alter initial MAP or pressor responses to noradrenaline in control rats, but significantly attenuated the LPS‐induced fall in MAP at 15 to 60 min after LPS. Dexamethasone did not influence the development of the LPS‐induced immediate (within 60 min) hyporeactivity to noradrenaline. However, dexamethasone pretreatment prevented the hypotension and vascular hyporeactivity at 180 min. 5 At 60 min after LPS a moderate increase in the activity of a calcium‐independent (inducible) NOS activity was detected in the aorta, but not in any of the other tissues studied. However, at 180 min after LPS, a significant NOS induction was observed in the lung, liver, spleen, mesentery, heart and aorta. This NOS induction was substantially prevented by pretreatment with dexamethasone. 6 These results suggest that the immediate hypotension and vascular hyporeactivity to noradrenaline in endotoxin shock is caused by an enhanced formation of NO due to activation of the constitutive enzyme. The delayed hypotension and vascular hyporeactivity, however, is due to enhanced NO formation by the LPS‐induced enzyme.
doi_str_mv 10.1111/j.1476-5381.1993.tb12879.x
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1908041</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>75653065</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5739-f81f288a710c650dd3a252a14e2899159ad7be8055ac67a54165b86931da9a563</originalsourceid><addsrcrecordid>eNqVkc2O0zAUhS0EGjqFR0CyEGLXYCfxT1ggYAQM0ghYwNq6tR3iktrFdodmVjwCz8iTkNCoGpZYsnzl893jax2EHlNS0HE92xS0FnzFKkkL2jRVkde0lKIpDnfQ4iTdRQtCiFhRKuV9dJ7ShpBRFOwMnQkuS1qJBbr54HJ0GoeDM_b3z19baxxka3A37EK0oLO7dnnAOWAfIphoPfTOW7yLVltjE86dxc6b_UgGj0OL_S1HnAafO0gTgq03IY_XHqcu6G8P0L0W-mQfzucSfXn75vPF5erq47v3F6-uVpqJqlm1krallCAo0ZwRYyooWQm0tqVsGsoaMGJtJWEMNBfAasrZWvKmogYaYLxaohdH391-PX5PW58j9GoX3RbioAI49a_iXae-hmtFGyJJTUeDp7NBDN_3NmW1dUnbvgdvwz4pwTiryLiX6PkR1DGkFG17eoQSNSWnNmqKR03xqCk5NSenDmPzo9tjnlrnqEb9yaxD0tC3Ebx26YTVnJecTdjLI_bD9Xb4jwHU60-Xf8vqD6oguvo</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>75653065</pqid></control><display><type>article</type><title>Nitric oxide‐mediated hyporeactivity to noradrenaline precedes the induction of nitric oxide synthase in endotoxin shock</title><source>PubMed Central</source><creator>Szabó, Csaba ; Mitchell, Jane A. ; Thiemermann, Christoph ; Vane, John R.</creator><creatorcontrib>Szabó, Csaba ; Mitchell, Jane A. ; Thiemermann, Christoph ; Vane, John R.</creatorcontrib><description>1 The role of an enhanced formation of nitric oxide (NO) and the relative importance of the constitutive and inducible NO synthase (NOS) for the development of immediate (within 60 min) and delayed (at 180 min) vascular hyporeactivity to noradrenaline was investigated in a model of circulatory shock induced by endotoxin (lipopolysaccharide; LPS) in the rat. 2 Male Wistar rats were anaesthetized and instrumented for the measurement of mean arterial blood pressure (MAP) and heart rate. In addition, the calcium‐dependent and calcium‐independent NOS activity was measured ex vivo by the conversion of [3H]‐arginine to [3H]‐citrulline in homogenates from several organs obtained from vehicle‐ and LPS‐treated rats. 3 E. coli LPS (10 mg kg−1, i.v. bolus) caused a rapid (within 5 min) and sustained fall in MAP. At 30 and 60 min after LPS, pressor responses to noradrenaline (0.3, 1 or 3 μg kg−1, i.v.) were significantly reduced. The pressor responses were restored by NG‐nitro‐l‐arginine methyl ester (l‐NAME, 1 mg kg−1, i.v. at 60 min), a potent inhibitor of NO synthesis. In contrast, l‐NAME did not potentiate the noradrenaline‐induced pressor responses in control animals. 4 Dexamethasone (3 mg kg−1, i.v., 60 min prior to LPS), a potent inhibitor of the induction of NOS, did not alter initial MAP or pressor responses to noradrenaline in control rats, but significantly attenuated the LPS‐induced fall in MAP at 15 to 60 min after LPS. Dexamethasone did not influence the development of the LPS‐induced immediate (within 60 min) hyporeactivity to noradrenaline. However, dexamethasone pretreatment prevented the hypotension and vascular hyporeactivity at 180 min. 5 At 60 min after LPS a moderate increase in the activity of a calcium‐independent (inducible) NOS activity was detected in the aorta, but not in any of the other tissues studied. However, at 180 min after LPS, a significant NOS induction was observed in the lung, liver, spleen, mesentery, heart and aorta. This NOS induction was substantially prevented by pretreatment with dexamethasone. 6 These results suggest that the immediate hypotension and vascular hyporeactivity to noradrenaline in endotoxin shock is caused by an enhanced formation of NO due to activation of the constitutive enzyme. The delayed hypotension and vascular hyporeactivity, however, is due to enhanced NO formation by the LPS‐induced enzyme.</description><identifier>ISSN: 0007-1188</identifier><identifier>EISSN: 1476-5381</identifier><identifier>DOI: 10.1111/j.1476-5381.1993.tb12879.x</identifier><identifier>PMID: 7682137</identifier><identifier>CODEN: BJPCBM</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Publishing Ltd</publisher><subject>Amino Acid Oxidoreductases - biosynthesis ; Anesthesia ; Animals ; Bacteriology ; Biological and medical sciences ; Blood Pressure - drug effects ; catecholamines ; circulatory shock ; Dexamethasone - pharmacology ; Enzyme Induction - drug effects ; Escherichia coli - metabolism ; Fundamental and applied biological sciences. Psychology ; Heart Rate - drug effects ; Hemodynamics - drug effects ; hypotension ; in vivo; nitric oxide synthase ; Lipopolysaccharide ; Lipopolysaccharides ; Male ; Microbiology ; Nitric Oxide - pharmacology ; Nitric Oxide Synthase ; Norepinephrine - pharmacology ; Pathogenicity, virulence, toxins, bacteriocins, pyrogens, host-bacteria relations, miscellaneous strains ; rat ; Rats ; Rats, Wistar ; Shock, Septic - enzymology ; Shock, Septic - physiopathology</subject><ispartof>British journal of pharmacology, 1993-03, Vol.108 (3), p.786-792</ispartof><rights>1993 British Pharmacological Society</rights><rights>1993 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5739-f81f288a710c650dd3a252a14e2899159ad7be8055ac67a54165b86931da9a563</citedby><cites>FETCH-LOGICAL-c5739-f81f288a710c650dd3a252a14e2899159ad7be8055ac67a54165b86931da9a563</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1908041/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1908041/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,724,777,781,882,27905,27906,53772,53774</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=4662657$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/7682137$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Szabó, Csaba</creatorcontrib><creatorcontrib>Mitchell, Jane A.</creatorcontrib><creatorcontrib>Thiemermann, Christoph</creatorcontrib><creatorcontrib>Vane, John R.</creatorcontrib><title>Nitric oxide‐mediated hyporeactivity to noradrenaline precedes the induction of nitric oxide synthase in endotoxin shock</title><title>British journal of pharmacology</title><addtitle>Br J Pharmacol</addtitle><description>1 The role of an enhanced formation of nitric oxide (NO) and the relative importance of the constitutive and inducible NO synthase (NOS) for the development of immediate (within 60 min) and delayed (at 180 min) vascular hyporeactivity to noradrenaline was investigated in a model of circulatory shock induced by endotoxin (lipopolysaccharide; LPS) in the rat. 2 Male Wistar rats were anaesthetized and instrumented for the measurement of mean arterial blood pressure (MAP) and heart rate. In addition, the calcium‐dependent and calcium‐independent NOS activity was measured ex vivo by the conversion of [3H]‐arginine to [3H]‐citrulline in homogenates from several organs obtained from vehicle‐ and LPS‐treated rats. 3 E. coli LPS (10 mg kg−1, i.v. bolus) caused a rapid (within 5 min) and sustained fall in MAP. At 30 and 60 min after LPS, pressor responses to noradrenaline (0.3, 1 or 3 μg kg−1, i.v.) were significantly reduced. The pressor responses were restored by NG‐nitro‐l‐arginine methyl ester (l‐NAME, 1 mg kg−1, i.v. at 60 min), a potent inhibitor of NO synthesis. In contrast, l‐NAME did not potentiate the noradrenaline‐induced pressor responses in control animals. 4 Dexamethasone (3 mg kg−1, i.v., 60 min prior to LPS), a potent inhibitor of the induction of NOS, did not alter initial MAP or pressor responses to noradrenaline in control rats, but significantly attenuated the LPS‐induced fall in MAP at 15 to 60 min after LPS. Dexamethasone did not influence the development of the LPS‐induced immediate (within 60 min) hyporeactivity to noradrenaline. However, dexamethasone pretreatment prevented the hypotension and vascular hyporeactivity at 180 min. 5 At 60 min after LPS a moderate increase in the activity of a calcium‐independent (inducible) NOS activity was detected in the aorta, but not in any of the other tissues studied. However, at 180 min after LPS, a significant NOS induction was observed in the lung, liver, spleen, mesentery, heart and aorta. This NOS induction was substantially prevented by pretreatment with dexamethasone. 6 These results suggest that the immediate hypotension and vascular hyporeactivity to noradrenaline in endotoxin shock is caused by an enhanced formation of NO due to activation of the constitutive enzyme. The delayed hypotension and vascular hyporeactivity, however, is due to enhanced NO formation by the LPS‐induced enzyme.</description><subject>Amino Acid Oxidoreductases - biosynthesis</subject><subject>Anesthesia</subject><subject>Animals</subject><subject>Bacteriology</subject><subject>Biological and medical sciences</subject><subject>Blood Pressure - drug effects</subject><subject>catecholamines</subject><subject>circulatory shock</subject><subject>Dexamethasone - pharmacology</subject><subject>Enzyme Induction - drug effects</subject><subject>Escherichia coli - metabolism</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Heart Rate - drug effects</subject><subject>Hemodynamics - drug effects</subject><subject>hypotension</subject><subject>in vivo; nitric oxide synthase</subject><subject>Lipopolysaccharide</subject><subject>Lipopolysaccharides</subject><subject>Male</subject><subject>Microbiology</subject><subject>Nitric Oxide - pharmacology</subject><subject>Nitric Oxide Synthase</subject><subject>Norepinephrine - pharmacology</subject><subject>Pathogenicity, virulence, toxins, bacteriocins, pyrogens, host-bacteria relations, miscellaneous strains</subject><subject>rat</subject><subject>Rats</subject><subject>Rats, Wistar</subject><subject>Shock, Septic - enzymology</subject><subject>Shock, Septic - physiopathology</subject><issn>0007-1188</issn><issn>1476-5381</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1993</creationdate><recordtype>article</recordtype><recordid>eNqVkc2O0zAUhS0EGjqFR0CyEGLXYCfxT1ggYAQM0ghYwNq6tR3iktrFdodmVjwCz8iTkNCoGpZYsnzl893jax2EHlNS0HE92xS0FnzFKkkL2jRVkde0lKIpDnfQ4iTdRQtCiFhRKuV9dJ7ShpBRFOwMnQkuS1qJBbr54HJ0GoeDM_b3z19baxxka3A37EK0oLO7dnnAOWAfIphoPfTOW7yLVltjE86dxc6b_UgGj0OL_S1HnAafO0gTgq03IY_XHqcu6G8P0L0W-mQfzucSfXn75vPF5erq47v3F6-uVpqJqlm1krallCAo0ZwRYyooWQm0tqVsGsoaMGJtJWEMNBfAasrZWvKmogYaYLxaohdH391-PX5PW58j9GoX3RbioAI49a_iXae-hmtFGyJJTUeDp7NBDN_3NmW1dUnbvgdvwz4pwTiryLiX6PkR1DGkFG17eoQSNSWnNmqKR03xqCk5NSenDmPzo9tjnlrnqEb9yaxD0tC3Ebx26YTVnJecTdjLI_bD9Xb4jwHU60-Xf8vqD6oguvo</recordid><startdate>199303</startdate><enddate>199303</enddate><creator>Szabó, Csaba</creator><creator>Mitchell, Jane A.</creator><creator>Thiemermann, Christoph</creator><creator>Vane, John R.</creator><general>Blackwell Publishing Ltd</general><general>Nature Publishing</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>199303</creationdate><title>Nitric oxide‐mediated hyporeactivity to noradrenaline precedes the induction of nitric oxide synthase in endotoxin shock</title><author>Szabó, Csaba ; Mitchell, Jane A. ; Thiemermann, Christoph ; Vane, John R.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5739-f81f288a710c650dd3a252a14e2899159ad7be8055ac67a54165b86931da9a563</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1993</creationdate><topic>Amino Acid Oxidoreductases - biosynthesis</topic><topic>Anesthesia</topic><topic>Animals</topic><topic>Bacteriology</topic><topic>Biological and medical sciences</topic><topic>Blood Pressure - drug effects</topic><topic>catecholamines</topic><topic>circulatory shock</topic><topic>Dexamethasone - pharmacology</topic><topic>Enzyme Induction - drug effects</topic><topic>Escherichia coli - metabolism</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Heart Rate - drug effects</topic><topic>Hemodynamics - drug effects</topic><topic>hypotension</topic><topic>in vivo; nitric oxide synthase</topic><topic>Lipopolysaccharide</topic><topic>Lipopolysaccharides</topic><topic>Male</topic><topic>Microbiology</topic><topic>Nitric Oxide - pharmacology</topic><topic>Nitric Oxide Synthase</topic><topic>Norepinephrine - pharmacology</topic><topic>Pathogenicity, virulence, toxins, bacteriocins, pyrogens, host-bacteria relations, miscellaneous strains</topic><topic>rat</topic><topic>Rats</topic><topic>Rats, Wistar</topic><topic>Shock, Septic - enzymology</topic><topic>Shock, Septic - physiopathology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Szabó, Csaba</creatorcontrib><creatorcontrib>Mitchell, Jane A.</creatorcontrib><creatorcontrib>Thiemermann, Christoph</creatorcontrib><creatorcontrib>Vane, John R.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>British journal of pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Szabó, Csaba</au><au>Mitchell, Jane A.</au><au>Thiemermann, Christoph</au><au>Vane, John R.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Nitric oxide‐mediated hyporeactivity to noradrenaline precedes the induction of nitric oxide synthase in endotoxin shock</atitle><jtitle>British journal of pharmacology</jtitle><addtitle>Br J Pharmacol</addtitle><date>1993-03</date><risdate>1993</risdate><volume>108</volume><issue>3</issue><spage>786</spage><epage>792</epage><pages>786-792</pages><issn>0007-1188</issn><eissn>1476-5381</eissn><coden>BJPCBM</coden><abstract>1 The role of an enhanced formation of nitric oxide (NO) and the relative importance of the constitutive and inducible NO synthase (NOS) for the development of immediate (within 60 min) and delayed (at 180 min) vascular hyporeactivity to noradrenaline was investigated in a model of circulatory shock induced by endotoxin (lipopolysaccharide; LPS) in the rat. 2 Male Wistar rats were anaesthetized and instrumented for the measurement of mean arterial blood pressure (MAP) and heart rate. In addition, the calcium‐dependent and calcium‐independent NOS activity was measured ex vivo by the conversion of [3H]‐arginine to [3H]‐citrulline in homogenates from several organs obtained from vehicle‐ and LPS‐treated rats. 3 E. coli LPS (10 mg kg−1, i.v. bolus) caused a rapid (within 5 min) and sustained fall in MAP. At 30 and 60 min after LPS, pressor responses to noradrenaline (0.3, 1 or 3 μg kg−1, i.v.) were significantly reduced. The pressor responses were restored by NG‐nitro‐l‐arginine methyl ester (l‐NAME, 1 mg kg−1, i.v. at 60 min), a potent inhibitor of NO synthesis. In contrast, l‐NAME did not potentiate the noradrenaline‐induced pressor responses in control animals. 4 Dexamethasone (3 mg kg−1, i.v., 60 min prior to LPS), a potent inhibitor of the induction of NOS, did not alter initial MAP or pressor responses to noradrenaline in control rats, but significantly attenuated the LPS‐induced fall in MAP at 15 to 60 min after LPS. Dexamethasone did not influence the development of the LPS‐induced immediate (within 60 min) hyporeactivity to noradrenaline. However, dexamethasone pretreatment prevented the hypotension and vascular hyporeactivity at 180 min. 5 At 60 min after LPS a moderate increase in the activity of a calcium‐independent (inducible) NOS activity was detected in the aorta, but not in any of the other tissues studied. However, at 180 min after LPS, a significant NOS induction was observed in the lung, liver, spleen, mesentery, heart and aorta. This NOS induction was substantially prevented by pretreatment with dexamethasone. 6 These results suggest that the immediate hypotension and vascular hyporeactivity to noradrenaline in endotoxin shock is caused by an enhanced formation of NO due to activation of the constitutive enzyme. The delayed hypotension and vascular hyporeactivity, however, is due to enhanced NO formation by the LPS‐induced enzyme.</abstract><cop>Oxford, UK</cop><pub>Blackwell Publishing Ltd</pub><pmid>7682137</pmid><doi>10.1111/j.1476-5381.1993.tb12879.x</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0007-1188
ispartof British journal of pharmacology, 1993-03, Vol.108 (3), p.786-792
issn 0007-1188
1476-5381
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1908041
source PubMed Central
subjects Amino Acid Oxidoreductases - biosynthesis
Anesthesia
Animals
Bacteriology
Biological and medical sciences
Blood Pressure - drug effects
catecholamines
circulatory shock
Dexamethasone - pharmacology
Enzyme Induction - drug effects
Escherichia coli - metabolism
Fundamental and applied biological sciences. Psychology
Heart Rate - drug effects
Hemodynamics - drug effects
hypotension
in vivo
nitric oxide synthase
Lipopolysaccharide
Lipopolysaccharides
Male
Microbiology
Nitric Oxide - pharmacology
Nitric Oxide Synthase
Norepinephrine - pharmacology
Pathogenicity, virulence, toxins, bacteriocins, pyrogens, host-bacteria relations, miscellaneous strains
rat
Rats
Rats, Wistar
Shock, Septic - enzymology
Shock, Septic - physiopathology
title Nitric oxide‐mediated hyporeactivity to noradrenaline precedes the induction of nitric oxide synthase in endotoxin shock
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-18T11%3A26%3A42IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Nitric%20oxide%E2%80%90mediated%20hyporeactivity%20to%20noradrenaline%20precedes%20the%20induction%20of%20nitric%20oxide%20synthase%20in%20endotoxin%20shock&rft.jtitle=British%20journal%20of%20pharmacology&rft.au=Szab%C3%B3,%20Csaba&rft.date=1993-03&rft.volume=108&rft.issue=3&rft.spage=786&rft.epage=792&rft.pages=786-792&rft.issn=0007-1188&rft.eissn=1476-5381&rft.coden=BJPCBM&rft_id=info:doi/10.1111/j.1476-5381.1993.tb12879.x&rft_dat=%3Cproquest_pubme%3E75653065%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c5739-f81f288a710c650dd3a252a14e2899159ad7be8055ac67a54165b86931da9a563%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=75653065&rft_id=info:pmid/7682137&rfr_iscdi=true